Analyst Ratings January 30, 2026

Mizuho Raises Eastman Chemical Price Target to $75 Citing Higher Market Multiples

Analyst keeps Outperform rating despite weaker Q4 2025 results and lowered near-term guidance

By Avery Klein EMN
Mizuho Raises Eastman Chemical Price Target to $75 Citing Higher Market Multiples
EMN

Mizuho increased its 12-month price target for Eastman Chemical (EMN) from $68.00 to $75.00 while retaining an Outperform rating. The lift in the target reflects higher market and peer valuation multiples even as the company reported softer fourth-quarter 2025 operating results and issued conservative near-term EPS guidance amid macro uncertainty.

Key Points

  • Mizuho raised its Eastman Chemical price target to $75.00 from $68.00 and retained an Outperform rating; the new target implies about 8.7% upside from $68.99.
  • Eastman reported adjusted EBIT of $134 million for Q4 2025, below Mizuho's $148 million estimate and the $156 million consensus; adjusted EPS was $0.75 and revenue was $1.97 billion, down 12% year-over-year.
  • Regional sales declined across the board in Q4: U.S. and Canada -8%, EMEA -16%, Asia Pacific -13.5%, Latin America -13.5%; global volume fell 11% and pricing dropped 2% year-over-year.

Mizuho has lifted its 12-month price target for Eastman Chemical Co. (NYSE: EMN) to $75.00 from $68.00 and kept an Outperform rating on the shares. The new target implies roughly an 8.7% potential upside from the stock's most recent price of $68.99. Data from InvestingPro shows Eastman trading at a price-to-earnings ratio of 11.37.

The broker stated that the higher target primarily reflects stronger market and peer multiples, even though Eastman reported weaker-than-expected results for the fourth quarter of 2025. Separately, InvestingPro's proprietary Fair Value model flags the stock as fairly valued and assigns the company an overall financial health rating of "GOOD."


Quarterly results and operating detail

Eastman posted adjusted earnings before interest and taxes (EBIT) of $134 million for the December quarter. That result was below Mizuho's internal estimate of $148 million and also missed the consensus level of $156 million.

Sales were weaker across regions in the quarter. U.S. and Canada sales declined 8% year-over-year, EMEA fell 16%, and both Asia Pacific and Latin America decreased 13.5% versus the prior-year period. On a consolidated basis, volumes dropped 11% and selling prices declined 2% compared with the year-ago quarter.

On the headline earnings line, Eastman reported adjusted earnings per share of $0.75 for the quarter, which matched analyst expectations. Revenue for the period came in at $1.97 billion, below the consensus forecast of $2.03 billion and representing a 12% decrease from the prior-year quarter. Company commentary attributed the revenue decline mainly to an 11% reduction in sales volume and mix and a 2% decrease in selling prices, partly offset by a favorable effect from foreign currency.


Guidance and near-term outlook

For the first quarter of 2026, Eastman provided an adjusted EPS range of $1.00 to $1.20, with a midpoint of $1.10. That midpoint sits below Mizuho's estimate of $1.43 and also under Bloomberg's consensus estimate of $1.31. Management said that macroeconomic uncertainty remains significant enough that it would not provide full-year guidance at this time.


Market performance and context

Eastman shares have declined 22.11% over the past 12 months but have recovered 8.08% year-to-date. The share-price reaction and Mizuho's decision to increase the price target underline a divergence between near-term operating weakness and higher peer or market valuation multiples that the broker used in its target revision.


What to watch next

Investors will likely monitor upcoming macro signals and any additional company commentary that could clarify demand trends, pricing stability, and currency impacts. The disparity between the firm's current-quarter results and the higher valuation assumptions applied by Mizuho points to a reliance on market multiple expansion rather than imminent operational improvement.


Note: InvestingPro figures referenced in this report reflect the metrics and model output cited by the analyst and company disclosures for fourth-quarter 2025 and first-quarter 2026 guidance.

Risks

  • Macroeconomic uncertainty could continue to pressure demand and pricing in the chemicals sector, affecting Eastman and peers - relevant to industrial and materials markets.
  • Near-term guidance is weaker than analyst expectations, with Q1 2026 midpoint EPS of $1.10 below both Mizuho and Bloomberg estimates, creating execution risk for short-term earnings - relevant to equity valuations and earnings-driven trading.
  • Reliance on higher market and peer multiples to justify a higher price target may leave the stock vulnerable if multiples compress rather than expand - relevant to investors focused on valuation and market sentiment.

More from Analyst Ratings

JPMorgan Lifts Chevron Price Target to $181, Citing Cost Cuts and Post-Merger Investment Phase Feb 2, 2026 H.C. Wainwright Sticks With Buy on Summit Therapeutics After FDA Accepts BLA Feb 2, 2026 Mizuho Lifts AXIS Capital Target After Strong 2025 Momentum Feb 2, 2026 JPMorgan Lifts ExxonMobil Target to $140 After Strong Q4 Results; Stock Near 52-Week High Feb 2, 2026 JPMorgan Reaffirms Overweight on Carvana, Cites Durable Online Advantage Feb 2, 2026